Leukaemia Trial, Recruiting NCT07278882 Sponsor: Institute of Hematology & Blood Diseases Hospital, China Condition: Leukaemia
Back to Leukaemia

Leukaemia Trial, Recruiting

NCT07278882
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were diagnosed before the age of 16.
  • People who have used a mobile app to log daily medication records and weekly blood test results consistently (more than 90% of the time) for at least 3 months.
  • People who are no longer receiving chemotherapy treatment in hospital.
  • People whose parent or legal guardian (or the patient themselves, where applicable) has agreed to take part by signing a consent form.

Who may not be able to join:

  • No exclusion criteria have been listed for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 022-23909051

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
20 November 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Percentage of time wherein white blood cell concentration is within the target range

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov